Suppr超能文献

FVB/Kras(LA2) 肺癌小鼠模型中的渐进性基因组不稳定性。

Progressive genomic instability in the FVB/Kras(LA2) mouse model of lung cancer.

机构信息

Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94158, USA.

出版信息

Mol Cancer Res. 2011 Oct;9(10):1339-45. doi: 10.1158/1541-7786.MCR-11-0219. Epub 2011 Aug 1.

Abstract

Alterations in DNA copy number contribute to the development and progression of cancers and are common in epithelial tumors. We have used array Comparative Genomic Hybridization (aCGH) to visualize DNA copy number alterations across the genomes of lung tumors in the Kras(LA2) model of lung cancer. Copy number gain involving the Kras locus, as focal amplification or whole chromosome gain, is the most common alteration in these tumors and with a prevalence that increased significantly with increasing tumor size. Furthermore, Kras amplification was the only major genomic event among the smallest lung tumors, suggesting that this alteration occurs early during the development of mutant Kras-driven lung cancers. Recurring gains and deletions of other chromosomes occur progressively more frequently among larger tumors. These results are in contrast to a previous aCGH analysis of lung tumors from Kras(LA2) mice on a mixed genetic background, in which relatively few DNA copy number alterations were observed regardless of tumor size. Our model features the Kras(LA2) allele on the inbred FVB/N mouse strain, and in this genetic background, there is a highly statistically significant increase in level of genomic instability with increasing tumor size. These data suggest that recurring DNA copy alterations are important for tumor progression in the Kras(LA2) model of lung cancer and that the requirement for these alterations may be dependent on the genetic background of the mouse strain.

摘要

DNA 拷贝数的改变有助于癌症的发展和进展,在上皮肿瘤中很常见。我们使用阵列比较基因组杂交 (aCGH) 来可视化肺癌 Kras(LA2)模型中肺肿瘤基因组中的 DNA 拷贝数改变。Kras 基因座的拷贝数增加,如局灶性扩增或整条染色体获得,是这些肿瘤中最常见的改变,而且随着肿瘤大小的增加,其普遍性显著增加。此外,Kras 扩增是最小的肺肿瘤中唯一的主要基因组事件,表明这种改变发生在突变 Kras 驱动的肺癌发展的早期。在较大的肿瘤中,其他染色体的重复获得和缺失逐渐更频繁地发生。这些结果与先前在混合遗传背景的 Kras(LA2)小鼠的肺肿瘤的 aCGH 分析形成对比,无论肿瘤大小如何,观察到的 DNA 拷贝数改变相对较少。我们的模型的特点是在近交 FVB/N 小鼠品系上的 Kras(LA2)等位基因,在这种遗传背景下,随着肿瘤大小的增加,基因组不稳定性的水平呈高度统计学显著增加。这些数据表明,反复出现的 DNA 拷贝改变对于肺癌 Kras(LA2)模型中的肿瘤进展很重要,并且这些改变的需求可能取决于小鼠品系的遗传背景。

相似文献

1
Progressive genomic instability in the FVB/Kras(LA2) mouse model of lung cancer.
Mol Cancer Res. 2011 Oct;9(10):1339-45. doi: 10.1158/1541-7786.MCR-11-0219. Epub 2011 Aug 1.
2
The mutational landscapes of genetic and chemical models of Kras-driven lung cancer.
Nature. 2015 Jan 22;517(7535):489-92. doi: 10.1038/nature13898. Epub 2014 Nov 2.
3
Oncogenic activating mutations are associated with local copy gain.
Mol Cancer Res. 2009 Aug;7(8):1244-52. doi: 10.1158/1541-7786.MCR-08-0532. Epub 2009 Aug 11.
4
Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinoma.
Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):E6409-E6417. doi: 10.1073/pnas.1613601113. Epub 2016 Oct 4.
5
Evaluation of Kras gene mutation and copy number gain in non-small cell lung cancer.
J Thorac Oncol. 2011 Jan;6(1):15-20. doi: 10.1097/JTO.0b013e31820594f0.
6
Protein kinase Cα suppresses Kras-mediated lung tumor formation through activation of a p38 MAPK-TGFβ signaling axis.
Oncogene. 2014 Apr 17;33(16):2134-44. doi: 10.1038/onc.2013.147. Epub 2013 Apr 22.
8
Amplification of Wild-type Imparts Resistance to Crizotinib in Exon 14 Mutant Non-Small Cell Lung Cancer.
Clin Cancer Res. 2018 Dec 1;24(23):5963-5976. doi: 10.1158/1078-0432.CCR-18-0876. Epub 2018 Aug 2.
10
Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer.
Mol Cancer Res. 2017 Jul;15(7):905-914. doi: 10.1158/1541-7786.MCR-16-0369. Epub 2017 Feb 27.

引用本文的文献

1
Comparative mRNA and miRNA transcriptome analysis of a mouse model of IGFIR-driven lung cancer.
PLoS One. 2018 Nov 9;13(11):e0206948. doi: 10.1371/journal.pone.0206948. eCollection 2018.
2
mutant genetically engineered mouse models of human cancers are genomically heterogeneous.
Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):E10947-E10955. doi: 10.1073/pnas.1708391114. Epub 2017 Dec 4.
3
4
Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer.
Mol Cancer Res. 2017 Jul;15(7):905-914. doi: 10.1158/1541-7786.MCR-16-0369. Epub 2017 Feb 27.
5
Epithelial cell migration as a potential therapeutic target in early lung cancer.
Eur Respir Rev. 2017 Jan 31;26(143). doi: 10.1183/16000617.0069-2016. Print 2017 Jan.
6
Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinoma.
Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):E6409-E6417. doi: 10.1073/pnas.1613601113. Epub 2016 Oct 4.
7
PIK3CA(H1047R) Accelerates and Enhances KRAS(G12D)-Driven Lung Tumorigenesis.
Cancer Res. 2015 Dec 15;75(24):5378-91. doi: 10.1158/0008-5472.CAN-15-1249. Epub 2015 Nov 13.
8
Statistical thermodynamics of transcription profiles in normal development and tumorigeneses in cohorts of patients.
Eur Biophys J. 2015 Dec;44(8):709-26. doi: 10.1007/s00249-015-1069-y. Epub 2015 Aug 20.
9
CDK2 Inhibition Causes Anaphase Catastrophe in Lung Cancer through the Centrosomal Protein CP110.
Cancer Res. 2015 May 15;75(10):2029-38. doi: 10.1158/0008-5472.CAN-14-1494. Epub 2015 Mar 25.

本文引用的文献

2
Germline variation controls the architecture of somatic alterations in tumors.
PLoS Genet. 2010 Sep 23;6(9):e1001136. doi: 10.1371/journal.pgen.1001136.
3
The cancer genome.
Nature. 2009 Apr 9;458(7239):719-24. doi: 10.1038/nature07943.
4
Kras regulatory elements and exon 4A determine mutation specificity in lung cancer.
Nat Genet. 2008 Oct;40(10):1240-4. doi: 10.1038/ng.211. Epub 2008 Aug 31.
5
A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors.
Genes Dev. 2007 Feb 15;21(4):379-84. doi: 10.1101/gad.1516407. Epub 2007 Feb 13.
6
A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2LA2 mice.
Nat Genet. 2006 Aug;38(8):926-30. doi: 10.1038/ng1836. Epub 2006 Jul 2.
7
Comparison of gene expression and DNA copy number changes in a murine model of lung cancer.
Genes Chromosomes Cancer. 2006 Apr;45(4):338-48. doi: 10.1002/gcc.20296.
8
Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis?
Trends Cell Biol. 2004 Nov;14(11):639-47. doi: 10.1016/j.tcb.2004.09.014.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验